1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Zydus Cadila Healthcare Limited – Product Pipeline Review –
2012
More about this report
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “Zydus Cadila Healthcare Limited -
Product Pipeline Review - 2012” provides data on the Zydus Cadila Healthcare
Limited’s research and development focus. The report includes information on
current developmental pipeline, complete with latest updates, and features on
discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Zydus Cadila Healthcare Limited’s corporate website, SEC
filings, investor presentations and featured press releases, both from Zydus Cadila
Healthcare Limited and industry-specific third party sources, put together by Global
Markets Direct’s team.
Scope
- Zydus Cadila Healthcare Limited - Brief Zydus Cadila Healthcare Limited overview
including business description, key information and facts, and its locations and
subsidiaries.
- Review of current pipeline of Zydus Cadila Healthcare Limited human therapeutic
division.
2. - Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:
List of Tables 6
List of Figures 7
Zydus Cadila Healthcare Limited Snapshot 8
Zydus Cadila Healthcare Limited Overview 8
Key Information 8
Key Facts 8
Zydus Cadila Healthcare Limited – Research and Development Overview 9
Key Therapeutic Areas 9
Zydus Cadila Healthcare Limited – Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products – Monotherapy 13
Zydus Cadila Healthcare Limited – Pipeline Products Glance 14
Zydus Cadila Healthcare Limited – Late Stage Pipeline 14
Registration Filed Products/Combination Treatment Modalities 14
Phase III Products/Combination Treatment Modalities 15
Zydus Cadila Healthcare Limited Clinical Stage Pipeline Products 16
Phase II Products/Combination Treatment Modalities 16
Phase I Products/Combination Treatment Modalities 17
Zydus Cadila Healthcare Limited – Early Stage Pipeline Products 18
Pre-Clinical Products/Combination Treatment Modalities 18
Discovery Products/Combination Treatment Modalities 19
Zydus Cadila Healthcare Limited – Drug Profiles 20
Blonanserin 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Drug For Atherosclerotic Plaque 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
3. IFN-Beta-1b 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
MAb 1 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
MAb 3 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
MAb 4 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
MacroGenics, Inc. – Product Pipeline Review – 2012
TopoTarget A/S – Product Pipeline Review – 2012
YM BioSciences Inc. – Product Pipeline Review – 2012
4. ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012
Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012
Acucela Inc. – Product Pipeline Review – 2012
Aldagen, Inc. – Product Pipeline Review – 2012
Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012
DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012
Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585